http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103432418-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-898 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-586 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-648 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 |
| filingDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103432418-B |
| titleOfInvention | Chinese medicine composition of a kind of gout pain relieving and its production and use |
| abstract | Chinese medicine composition of a kind of gout pain relieving and its production and use, belong to technical field of traditional Chinese medicine pharmacy, comprise following former spice or its extract: Herba Lysimachiae, Semen Plantaginis, Radix Stephaniae Tetrandrae, Cortex Phellodendri, Radix Codonopsis, Radix Angelicae Sinensis, Pheretima, Cornu Bubali, Radix Aconiti Preparata, Radix Aconiti Kusnezoffii Preparata, Scolopendra, arrowhead, Sargassum, Rhizoma Atractylodis, six is bent, Rhizoma Et Radix Notopterygii, Radix Clematidis, Flos Carthami, Herba Asari, Cortex Cinnamomi, Rhizoma Chuanxiong, Radix Angelicae Pubescentis, the Radix Paeoniae Alba, Chinese medicine composition of the present invention is according to the abstract science compatibility of tcm treatment according to syndrome differentiation, there is expelling wind and removing dampness, antalgic, rheumatic arthralgia, heat-clearing and toxic substances removing, numb limbs and tense tendons, arthralgia, heat clearing away is calmed the frightened, effect of deficiency of the spleen and lung, its cure rate is high, short treating period, relapse rate is low, toxic and side effects is few, to alleviating constitutional, secondary gout pain, cure gout and all achieve better effects, be worth carrying out promotion and application clinically. |
| priorityDate | 2013-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.